Problem:Cardiovascular risk reduction in obesity

From Pharmacopedia

Revision as of 06:01, 13 June 2026 by MDElliottMD (talk | contribs) (Launch A7: honest early-note placeholder (mark-tapped))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Nav

This page is early; a full clinical description is coming. The cross-linked medicines below are live.

Reduction of MACE in adults with obesity but without type 2 diabetes (SELECT trial indication).

Medicines used for Cardiovascular risk reduction in obesity

Semaglutide

Retrieved from "https://pharmacopedia.wiki/index.php?title=Problem:Cardiovascular_risk_reduction_in_obesity&oldid=7517"